| Literature DB >> 30589670 |
Guillaume Chaussé1, Jerome Laufer, Gad Abikhzer, Stephan Probst.
Abstract
A 69-year-old man with biochemical recurrence after radical prostatectomy underwent 6 months of androgen deprivation therapy. Upon discontinuation of androgen deprivation therapy, serum prostate-specific antigen rose again to 0.69 ng/mL, and F-DCFPyL PET/CT was performed to identify the site of recurrence. However, only an intense focus of uptake in the spleen could be found. Subsequent contrast-enhanced MRI findings were pathognomonic for splenic hemangioma.Entities:
Mesh：
Substances：
Year: 2019 PMID： 30589670 DOI： 10.1097/RLU.0000000000002428
Source DB: PubMed Journal: Clin Nucl Med ISSN： 0363-9762 Impact factor: 7.794